C Partners Holding’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,189
Closed -$128K 137
2018
Q3
$128K Sell
1,189
-1,478
-55% -$148K 0.04% 78
2018
Q2
$228K Sell
2,667
-68
-2% -$5.58K 0.09% 130
2018
Q1
$212K Sell
2,735
-468
-15% -$37.7K 0.09% 150
2017
Q4
$271K Buy
+3,203
New +$273K 0.11% 143

Other funds holding LLY

C Partners Holding's LLY Position: Q4 2018 in Review

C Partners Holding sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 1,189 shares — an estimated $128K sold.

C Partners Holding first reported a position in LLY in Q4 2017 and held it in 4 quarters. The position peaked at $271K in Q4 2017. 1,561 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • C Partners Holding reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 1,189 Eli Lilly shares in Q4 2018, an estimated $128K.
  • C Partners Holding first reported a position in Eli Lilly in Q4 2017 and held it in 4 quarters.
  • C Partners Holding's Eli Lilly position peaked at $271K in Q4 2017.
  • 1,561 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.